Patents by Inventor Jess Thoene

Jess Thoene has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cysteamine for the Treatment, Mitigation and Prevention of Coronaviral, e.g., SARS-CoV-2, Infections
    Publication number: 20220000808
    Abstract: Provided herein are methods for the treatment, mitigation, and prevention of viral infections (e.g., coronavirus infections (e.g., severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etc.), etc.) and diseases (e.g., Coronavirus disease 2019 (COVID-19)) associated therewith by the administration of cysteamine or derivatives thereof to a subject.
    Type: Application
    Filed: September 15, 2021
    Publication date: January 6, 2022
    Inventors: Jess THOENE, Robert GAVIN
  • Extracellular vesicles comprising recombinant lysosomal transmembrane protein
    Patent number: 9566314
    Abstract: The present invention provides compositions and methods for providing factor replacement therapy. In particular, the present invention provides replacement therapy for subjects suffering from cystinosis.
    Type: Grant
    Filed: April 21, 2015
    Date of Patent: February 14, 2017
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Jess Thoene, Jeffrey Innis
  • CYSTINOSIN REPLACEMENT FACTOR
    Publication number: 20150216930
    Abstract: The present invention provides compositions and methods for providing factor replacement therapy. In particular, the present invention provides replacement therapy for subjects suffering from cystinosis.
    Type: Application
    Filed: April 21, 2015
    Publication date: August 6, 2015
    Inventors: Jess Thoene, Jeffrey Innis
  • Cystinosin replacement factor
    Patent number: 9023798
    Abstract: The present invention provides compositions and methods for providing factor replacement therapy. In particular, the present invention provides replacement therapy for subjects suffering from cystinosis.
    Type: Grant
    Filed: July 23, 2010
    Date of Patent: May 5, 2015
    Assignee: The Regents of the University of Michigan
    Inventors: Jess Thoene, Jeffrey Innis
  • FACTOR REPLACEMENT THERAPY
    Publication number: 20110020411
    Abstract: The present invention provides compositions and methods for providing factor replacement therapy. In particular, the present invention provides replacement therapy for subjects suffering from cystinosis.
    Type: Application
    Filed: July 23, 2010
    Publication date: January 27, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Jess Thoene, Jeffrey Innis
  • Methods and compositions for treating cancer
    Publication number: 20070078093
    Abstract: Pharmaceutical compositions and kits useful for the treatment of cancer include certain alkyl esters of cystine and certain alkyl-substituted cystamine derived esters, including, for example, cystine dimethyl ester and a di-alkyl peptidyl cystamine ester, among others. These compounds may be employed in methods of treating cancers or methods of determining sensitivity of certain cancer cells to apoptosis alone, or in combination with other chemotherapeutic, radiological or apoptotic agents.
    Type: Application
    Filed: October 15, 2004
    Publication date: April 5, 2007
    Applicant: The Administrators of the Tulane Educational Fund
    Inventor: Jess Thoene